HER2 status predicts for upfront AI benefit: a TRANS-AIOG meta-analysis of 12,129 patients from ATAC, BIG 1-98 and TEAM with centrally determined HER2

- Bartlett, John M. S., Ahmed, Ikhlaaq, Brookes, Cassandra L., Forbes, John F., Viale, Giuseppe, Cuzick, Jack, Dowsett, Mitchell, Rea, Daniel W., Regan, Meredith M., Sestak, Ivana, Mallon, Elizabeth A., Dell'Orto, Patrizia, Thürlimann, Beat, Seynaeve, Caroline, Putter, Hein, Van de Velde, Cornelis J. H.

Are we there yet?: the state of the evidence base for guidelines on breaking bad news to cancer patients

- Paul, C. L., Clinton-McHarg, T., Sanson-Fisher, R. W., Douglas, H., Webb, G.

Unmet needs and depression among carers of people newly diagnosed with cancer

- Heckel, L., Fennell, K. M., Reynolds, J., Osborne, R. H., Chirgwin, J., Botti, M., Ashley, D. M., Livingston, P. M.

Determining research priorities for young people with haematological cancer: a value-weighting approach

- Clinton-McHarg, Tara, Paul, Christine, Sanson-Fisher, Rob, D'Este, Catherine, Williamson, Anna

Common variants of DNA repair genes and malignant melanoma

- Debniak, T., Scott, R. J., Kowalska, E., Jakubowska, A., Gronwald, J., Wokolorczyk, D., Maleszka, R., Kładny, J., Lubinski, J., Gorski, B., Cybulskia, C., van de Wetering, T., Serrano-Fernandez, P., Huzarski, T., Byrski, T., Nagay, L., Dębniak, B.

Enlisting the willing: a study of healthcare professional-initiated and opt-in biobanking consent reveals improvement opportunities throughout the registration process

- Fradgley, Elizabeth A., Chong, Shu Er, Cox, Martine E., Paul, Christine L., Gedye, Craig

The impact on health-related quality of life in the first 12 months: a randomised comparison of preoperative short-course radiation versus long-course chemoradiation for T3 rectal cancer (Trans-Tasman Radiation Oncology Group Trial 01.04)

- McLachlan, Sue-Anne, Fisher, Richard J., MacKay, John, Ngan, Samuel Y., Zalcberg, John, Solomon, Michael, Burmeister, Bryan, Goldstein, David, Leong, Trevor, Ackland, Stephen P., McKendrick, Joseph, McClure, Bev

Final 10-year results of the Breast International Group 2–98 phase III trial and the role of Ki67 in predicting benefit of adjuvant docetaxel in patients with oestrogen receptor positive breast cancer

- Sonnenblick, Amir, Francis, Prudence A., Lluch, Ana, Gnant, Michael, Goldhirsch, Aron, Di Leo, Angelo, Barnadas, Agusti, Cortes-Funes, Hernan, Piccart, Martine, Crown, John, Azim Jr, Hatem A., de Azambuja, Evandro, Nordenskjold, Bo, Gutierez, Jorge, Quinaux, Emmanuel, Mastropasqua, Mauro G., Ameye, Lieveke, Anderson, Michael

Are Australian oncology health professionals burning out?: a view from the trenches

- Girgis, Afaf, Hansen, Vibeke, Goldstein, David

Solaria compliance in an unregulated environment: the Australian experience

- Paul, C. L., Stacey, F., Girgis, A., Brozek, I., Baird, H., Hughes, J.